The Changing landscape of renal inflammation

Trends in Molecular Medicine

Volumn 22, Issue 2, 2016, Pages 151-163

  Ernandez, Thomas ^a   Mayadas, Tanya Norton ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chemokines; Effector immune cells; Environmental triggers; Glomerulus; Leukocyte recruitment; Local inflammation; Phenotype stability; Regulatory immune cells

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; CXCL13 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL CYTOPLASMIC ANTIBODY; RANTES; SODIUM; TOCILIZUMAB; TUMOR NECROSIS FACTOR; UREMIC TOXIN; CYTOKINE; IMMUNOLOGIC FACTOR;

ANCA ASSOCIATED VASCULITIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ADHESION; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; HUMAN; IMMUNE COMPLEX NEPHRITIS; IMMUNOCOMPETENT CELL; INTERSTITIAL NEPHRITIS; KIDNEY ISCHEMIA; LEUKOCYTE; MICROENVIRONMENT; MICROFLORA; MONOCYTE; NONHUMAN; PYELONEPHRITIS; REGULATORY T LYMPHOCYTE; REVIEW; SUPPRESSOR CELL; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; KIDNEY; KIDNEY FAILURE, CHRONIC; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; TH1 CELL; TUMOR MICROENVIRONMENT;

CELL MOVEMENT; CELLULAR MICROENVIRONMENT; CYTOKINES; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; INFLAMMATION; KIDNEY; KIDNEY FAILURE, CHRONIC; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 84960343018     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2015.12.002     Document Type: Review

References (116)

1. Saran R., et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am. J. Kidney Dis. 2015, 65(Suppl. 1):A7.
2. Ley K., et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
3. Thomas G., et al. Nonclassical patrolling monocyte function in the vasculature. Arterioscler. Thromb. Vasc. Biol. 2015, 35:1306-1316.
4. Devi S., et al. Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus. Nat. Med. 2013, 19:107-112.
5. Block H., et al. Crucial role of SLP-76 and ADAP for neutrophil recruitment in mouse kidney ischemia-reperfusion injury. J. Exp. Med. 2012, 209:407-421.
6. + T cell migration to vascularized transplants. J. Clin. Invest. 2013, 123:2663-2671.
7. McDonald B., et al. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J. Exp. Med. 2008, 205:915-927.
8. McDonald B., et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010, 330:362-366.
9. Mayadas T.N., et al. Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury. Circulation 2009, 120:2012-2024.
10. Wada T., et al. The role of chemokines in glomerulonephritis. Front. Biosci. 2008, 13:3966-3974.
11. Chung A.C., Lan H.Y. Chemokines in renal injury. J. Am. Soc. Nephrol. 2011, 22:802-809.
12. Panzer U., et al. Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J. Am. Soc. Nephrol. 2007, 18:2071-2084.
13. Menke J., et al. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. J. Am. Soc. Nephrol. 2008, 19:1177-1189.
14. Steinmetz O.M., et al. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J. Immunol. 2009, 183:4693-4704.
15. Romagnani P., et al. IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J. Am. Soc. Nephrol. 2002, 13:53-64.
16. + T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients. Arthritis Rheum. 2009, 60:199-206.
17. Abujam B., et al. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis. Lupus 2013, 22:614-623.
18. Turner J.E., et al. The Th17 immune response in renal inflammation. Kidney Int. 2010, 77:1070-1075.
19. Azadegan-Dehkordi F., et al. The role of Th1 and Th17 cells in glomerulonephritis. J. Nephropathol. 2015, 4:32-37.
20. Paust H.J., et al. Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis. Kidney Int. 2012, 82:72-83.
21. Disteldorf E.M., et al. CXCL5 drives neutrophil recruitment in TH17-mediated GN. J. Am. Soc. Nephrol. 2015, 26:55-66.
22. Dong X., et al. Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction. Kidney Int. 2008, 74:1294-1309.
23. Worthmann K., et al. Pathogenetic role of glomerular CXCL13 expression in lupus nephritis. Clin. Exp. Immunol. 2014, 178:20-27.
24. Wong C.K., et al. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J. Clin. Immunol. 2010, 30:45-52.
25. Schiffer L., et al. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol. Dial. Transplant. 2009, 24:3708-3712.
26. Brix S.R., et al. CC chemokine ligand 18 in ANCA-associated crescentic GN. J. Am. Soc. Nephrol. 2015, 26:2105-2117.
27. Timoshanko J.R., et al. Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J. Am. Soc. Nephrol. 2003, 14:1785-1793.
28. Ernandez T., Mayadas T.N. Immunoregulatory role of TNFalpha in inflammatory kidney diseases. Kidney Int. 2009, 76:262-276.
29. Aringer M., Smolen J.S. Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus. Expert Opin. Drug Saf. 2008, 7:411-419.
30. Charles P.J., et al. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum. 2000, 43:2383-2390.
31. De Bandt M., et al. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res. Ther. 2005, 7:R545-R551.
32. Debes G.F., et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 2005, 6:889-894.
33. Bromley S.K., et al. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 2005, 6:895-901.
34. Hopken U.E., et al. CCR7 regulates lymphocyte egress and recirculation through body cavities. J. Leukoc. Biol. 2010, 87:671-682.
35. Herter J.M., et al. AKAP9 regulates activation-induced T lymphocyte retention at sites of inflammation. Nat. Commun. 2015, Published online December 18, 2015. 10.1038/ncomms10182.
36. Kolaczkowska E., Kubes P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 2013, 13:159-175.
37. Mayadas T.N., et al. Neutrophils: game changers in glomerulonephritis?. Trends Mol. Med. 2010, 16:368-378.
38. Kaplan M.J. Neutrophils in the pathogenesis and manifestations of SLE. Nat. Rev. Rheumatol. 2011, 7:691-699.
39. Villanueva E., et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 2011, 187:538-552.
40. Camussi G., et al. The polymorphonuclear neutrophil (PMN) immunohistological technique: detection of immune complexes bound to the PMN membrane in acute poststreptococcal and lupus nephritis. Clin. Nephrol. 1980, 14:280-287.
41. Hakkim A., et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9813-9818.
42. Rosetti F., et al. Human lupus serum induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency. J. Immunol. 2012, 189:3714-3723.
43. Teramoto K., et al. Microarray analysis of glomerular gene expression in murine lupus nephritis. J. Pharmacol. Sci. 2008, 106:56-67.
44. Bennett L., et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 2003, 197:711-723.
45. Hacbarth E., Kajdacsy-Balla A. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum. 1986, 29:1334-1342.
46. Denny M.F., et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol. 2010, 184:3284-3297.
47. Kleinewietfeld M., et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013, 496:518-522.
48. Wu C., et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013, 496:513-517.
49. Safa K., et al. Salt accelerates allograft rejection through serum- and glucocorticoid-regulated kinase-1-dependent inhibition of regulatory T cells. J. Am. Soc. Nephrol. 2015, 26:2341-2347.
50. Zewinger S., et al. Innate immunity in CKD-associated vascular diseases. Nephrol. Dial. Transplant. 2015, Published online October 9, 2015. 10.1093/ndt/gfv358.
51. Kurts C., et al. The immune system and kidney disease: basic concepts and clinical implications. Nat. Rev. Immunol. 2013, 13:738-753.
52. Adesso S., et al. The uremic toxin indoxyl sulphate enhances macrophage response to LPS. PLoS ONE 2013, 8:e76778.
53. Mansouri L., et al. Leukocyte proliferation and immune modulator production in patients with chronic kidney disease. PLoS ONE 2013, 8:e73141.
54. Al-Chaqmaqchi H.A., et al. Activation of Wnt/beta-catenin pathway in monocytes derived from chronic kidney disease patients. PLoS ONE 2013, 8:e68937.
55. Hevia A., et al. Intestinal dysbiosis associated with systemic lupus erythematosus. MBio 2014, 5:e01548.
56. De Angelis M., et al. Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN). PLoS ONE 2014, 9:e99006.
57. McCarthy D.D., et al. Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J. Clin. Invest. 2011, 121:3991-4002.
58. hi cells. Nature 2013, 494:116-120.
59. Kiryluk K., et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat. Genet. 2014, 46:1187-1196.
60. + regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. Kidney Int. 2014, 78:1100-1109.
61. Ostmann A., et al. Regulatory T cell-derived IL-10 ameliorates crescentic GN. J. Am. Soc. Nephrol. 2013, 24:930-942.
62. Turner J.E., et al. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J. Am. Soc. Nephrol. 2010, 21:974-985.
63. Eller K., et al. CCR7 deficiency exacerbates injury in acute nephritis due to aberrant localization of regulatory T cells. J. Am. Soc. Nephrol. 2010, 21:42-52.
64. + T-regulatory cells suppress anti-glomerular basement membrane nephritis. Kidney Int. 2011, 79:977-986.
65. Kluger M.A., et al. Stat3 programs Th17-specific regulatory T cells to control GN. J. Am. Soc. Nephrol. 2014, 25:1291-1302.
66. Paust H.J., et al. Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis. Kidney Int. 2011, 80:154-164.
67. Tan D.S., et al. Thymic deletion and regulatory T cells prevent antimyeloperoxidase GN. J. Am. Soc. Nephrol. 2013, 24:573-585.
68. + regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int. 2009, 76:717-729.
69. Kinsey G.R., et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J. Am. Soc. Nephrol. 2009, 20:1744-1753.
70. Kinsey G.R., et al. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int. 2010, 77:771-780.
71. + regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J. Am. Soc. Nephrol. 2005, 16:1360-1370.
72. Chow Z., et al. Controlling the fire - tissue-specific mechanisms of effector regulatory T-cell homing. Immunol. Cell Biol. 2015, 93:355-363.
73. Yoshimura J., et al. Interstitial Foxp3-positive T cells may predict renal survival in patients with myeroperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Clin. Exp. Pharmacol. Physiol. 2010, 37:879-883.
74. high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 2007, 178:2579-2588.
75. + Treg cells decrease in patients with lupus nephritis. Rheumatol. Int. 2012, 32:949-958.
76. Afeltra A., et al. The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study. Intern. Emerg. Med. 2015, 10:677-683.
77. Comte D., et al. T cells as a therapeutic target in SLE. Lupus 2015, 24:351-363.
78. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9:162-174.
79. Crook K.R. Role of myeloid-derived suppressor cells in autoimmune disease. World J. Immunol. 2014, 4:26.
80. Slaney C.Y., et al. Naive blood monocytes suppress T-cell function. A possible mechanism for protection from autoimmunity. Immunol. Cell Biol. 2011, 89:7-13.
81. Dugast A.S., et al. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J. Immunol. 2008, 180:7898-7906.
82. + Treg expansion. Am. J. Transplant. 2013, 13:3123-3131.
83. Li L., et al. Role of myeloid-derived suppressor cells in glucocorticoid-mediated amelioration of FSGS. J. Am. Soc. Nephrol. 2015, 26:2183-2197.
84. Auffray C., et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007, 317:666-670.
85. low monocytes monitor endothelial cells and orchestrate their disposal. Cell 2013, 153:362-375.
86. low monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1. J. Immunol. 2009, 182:2777-2785.
87. + double-positive cells in periodontitis. J. Dent. Res. 2012, 91:574-579.
88. dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010, 33:375-386.
89. high monocytes protect against kidney damage during sepsis via a CX3CR1-dependent adhesion mechanism. J. Am. Soc. Nephrol. 2015, Published online July 9, 2015. 10.1681/ASN.2015010009.
90. Hochheiser K., et al. Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression. J. Clin. Invest. 2013, 123:4242-4254.
91. pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008, 112:2340-2352.
92. + T cells. Science 2010, 327:1098-1102.
93. Zhou X., et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 2009, 10:1000-1007.
94. + regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J. Invest. Dermatol. 2011, 131:1853-1860.
95. + T cells. Nat. Commun. 2014, 5:1-12.
96. + regulatory T cells in humans. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4793-4798.
97. + cells are an independent bifunctional regulatory T cell lineage and mediate crescentic GN. J. Am. Soc. Nephrol. 2015, Published online June 8, 2015. 10.1681/ASN.2014090880.
98. Schmidt T., et al. Function of the Th17/interleukin-17A immune response in murine lupus nephritis. Arthritis Rheumatol. 2015, 67:475-487.
99. Hogan J.J., et al. Drug-induced glomerular disease: immune-mediated injury. Clin. J. Am. Soc. Nephrol. 2015, 10:1300-1310.
100. Ramos-Casals M., et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine 2007, 86:242-251.
101. Smolen J.S., et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 2008, 371:987-997.
102. Luig M., et al. Inflammation-induced IL-6 functions as a natural brake on macrophages and limits GN. J. Am. Soc. Nephrol. 2015, 26:1597-1607.
103. Wendling D., et al. Psoriasis onset with tocilizumab treatment for rheumatoid arthritis. J. Rheumatol. 2012, 39:657.
104. Matsuo Y., et al. Tocilizumab-induced immune complex glomerulonephritis in a patient with rheumatoid arthritis. Rheumatology 2013, 52:1341-1343.
105. Scalapino K.J., et al. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 2006, 177:1451-1459.
106. Lai L.W., et al. Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury. Kidney Int. 2012, 81:983-992.
107. Braza F., et al. Regulatory T cells in kidney transplantation: new directions?. Am. J. Transplant. 2015, 15:2288-2300.
108. Venkatesh D., et al. Endothelial TNF receptor 2 induces IRF1 transcription factor-dependent interferon-beta autocrine signaling to promote monocyte recruitment. Immunity 2013, 38:1025-1037.
109. Vielhauer V., et al. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J. Clin. Invest. 2005, 115:1199-1209.
110. Scheller J., et al. ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol. 2011, 32:380-387.
111. Al-Lamki R.S., et al. TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J. 2005, 19:1637-1645.
112. Taubitz A., et al. Distinct contributions of TNF receptor 1 and 2 to TNF-induced glomerular inflammation in mice. PLoS ONE 2013, 8:e68167.
113. Santee S.M., Owen-Schaub L.B. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J. Biol. Chem. 1996, 271:21151-21159.
114. Gosselin D., et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 2014, 159:1327-1340.
115. Ko G.J., et al. Transcriptional analysis of infiltrating T cells in kidney ischemia-reperfusion injury reveals a pathophysiological role for CCR5. Am. J. Physiol. Renal Physiol. 2012, 302:F762-F773.
116. Tsuboi N., et al. Human neutrophil Fcγ receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Immunity 2008, 28:833-846.